Harnessing host–virus evolution in antiviral therapy and immunotherapy
Abstract Pathogen resistance and development costs are major challenges in current approaches to antiviral therapy. The high error rate of RNA synthesis and reverse‐transcription confers genome plasticity, enabling the remarkable adaptability of RNA viruses to antiviral intervention. However, this p...
| Hlavní autor: | |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Wiley
2019-01-01
|
| Edice: | Clinical & Translational Immunology |
| Témata: | |
| On-line přístup: | https://doi.org/10.1002/cti2.1067 |